Fangzhou Inc. (HKG:6086)
Hong Kong · Delayed Price · Currency is HKD 0.8600
+0.0100 (1.18%)
Oct 2, 2026, 4:08 PM HKT
Fangzhou Revenue
Fangzhou had revenue of 1.82B CNY in the half year ending June 30, 2026, with 37.92% growth. This brings the company's revenue in the last twelve months to 3.86B, up 34.01% year-over-year. In the year 2025, Fangzhou had annual revenue of 3.53B with 30.24% growth.
Revenue (ttm)
3.86B CNY
Revenue Growth
+34.01%
P/S Ratio
0.27
Revenue / Employee
7.50M CNY
Employees
514
Market Cap
1.19B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.53B | 818.79M | 30.24% |
| Dec 31, 2024 | 2.71B | 273.06M | 11.22% |
| Dec 31, 2023 | 2.43B | 230.01M | 10.43% |
| Dec 31, 2022 | 2.20B | 445.63M | 25.34% |
| Dec 31, 2021 | 1.76B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 91.25B |
| Alibaba Health Information Technology | 38.94B |
| YSB Inc. | 24.72B |
| Shanghai Pioneer Holding | 1.43B |
| Tycoon Group Holdings | 1.08B |
| Kingworld Medicines Group | 909.57M |
| Universal Health International Group Holding | 599.41M |
| New Ray Medicine International Holding | 199.09M |